Cargando…
HMGB1 is a Potential Mediator of Astrocytic TLR4 Signaling Activation following Acute and Chronic Focal Cerebral Ischemia
Limited, and underutilized, therapeutic options for acute stroke require new approaches to treatment. One such potential approach involves better understanding of innate immune response to brain injury such as acute focal cerebral ischemia. This includes understanding the temporal profile, and speci...
Autores principales: | Famakin, Bolanle M., Tsymbalyuk, Orest, Tsymbalyuk, Natalia, Ivanova, Svetlana, Woo, Seung Kyoon, Kwon, Min Seong, Gerzanich, Volodymyr, Simard, J. Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053497/ https://www.ncbi.nlm.nih.gov/pubmed/32148958 http://dx.doi.org/10.1155/2020/3929438 |
Ejemplares similares
-
Canagliflozin, an Inhibitor of the Na(+)-Coupled D-Glucose Cotransporter, SGLT2, Inhibits Astrocyte Swelling and Brain Swelling in Cerebral Ischemia
por: Shim, Bosung, et al.
Publicado: (2023) -
Brivaracetam attenuates pain behaviors in a murine model of
neuropathic pain
por: Tsymbalyuk, Solomiya, et al.
Publicado: (2019) -
Traumatic brain injury alters dendritic cell differentiation and distribution in lymphoid and non-lymphoid organs
por: Tsymbalyuk, Orest, et al.
Publicado: (2022) -
Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of Stroke
por: Simard, J. Marc, et al.
Publicado: (2012) -
SUR1, newly expressed in astrocytes, mediates neuropathic pain in a
mouse model of peripheral nerve injury
por: Tsymbalyuk, Orest, et al.
Publicado: (2021)